BioSpace News Archive

Business

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

Beroni Group announced that it has appointed Dr. John Chiplin as an independent director to Beroni’s Board of Directors effective April 1, 2022.

March 31, 2022
·
4 min read
Business

NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results

Company to Host Conference Call and Webcast March 31, 2022 , at 8:30am ET to announce its financial results for the year ended December 31, 2021 and provide a business update.

March 31, 2022
·
10 min read
Biotech Bay

I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Suggests No Clinical Benefit with Addition of Nebulized ZYESAMI® (aviptadil) When Given by Mouth Inhalation in Critically Ill Patients with COVID-19

Quantum Leap Healthcare Collaborative (QLHC) announced in collaboration with NRx Pharmaceuticals, Inc. (NRx), that the nebulized form of ZYESAMI ® (Aviptadil), in the I-SPY COVID Trial of Critical COVID-19 patients has been stopped.

March 31, 2022
·
8 min read
Business

Totus Medicines Announces New San Francisco Bay Area Headquarters & Expanded Lab Space

Totus Medicines, the drug discovery company harnessing proprietary chemical biology and AI to address previously untreatable cancers, announced the relocation of its headquarters to Emeryville, California.

March 31, 2022
·
2 min read
BioMidwest

Artivion to Participate in the 21st Annual Needham Virtual Healthcare Conference

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it will participate at the upcoming 21st Annual Needham Virtual Healthcare Conference.

March 31, 2022
·
1 min read
Drug Development

Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®

Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau.

March 31, 2022
·
5 min read
Pharm Country

Marinus Pharmaceuticals Bolsters Financial Position With Drawdown of $30 Million Under Oaktree Capital Credit Facility

Marinus Pharmaceuticals , Inc. today announced it has received $30 million in funding under the existing Oaktree Capital Management, L.P. (Oaktree) credit agreement.

March 31, 2022
·
5 min read
Drug Development

HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in TRD, suggesting antidepressant efficacy and showing Placebo-Level Dissociative Side Effects in Phase 2 oral prolonged-release Ketamine (KET01) Study

HMNC Brain Health announced promising top-line results from the Phase 2 Proof-of-Concept investigator-initiated trial of its oral prolonged-release formulation of ketamine in Treatment-Resistant Depression.

March 31, 2022
·
7 min read
Business

Celsion Corporation Reports 2021 Financial Results and Provides Business Update

Celsion Corporation today announced financial results for the year ended December 31, 2021, and provided an update.

March 31, 2022
·
21 min read
Deals

Acer Therapeutics Regains Compliance with Nasdaq Listing Standard

Acer Therapeutics Inc. today announced that it has received notice from The Nasdaq Stock Market (Nasdaq) on March 30, 2022 informing Acer that it has regained compliance with the minimum market value of listed securities standard under Nasdaq List Standard.

March 31, 2022
·
1 min read